AVIR Atea Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1593899 · EDGAR
- Bought, last 12 months
- $25.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 80 since 2021-12-21, latest 2026-06-23 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Murphy Polly A. | Dir | $25.4K | — |
| Adams Jerome M. | Dir | — | — |
| Hammond Janet MJ | Chief Development Off | — | — |
| Vavricka John | Chief Commercial Off | — | — |
| Lucidi Bruno | Dir | — | — |
| Horga Maria Arantxa | Chief Medical Off | — | — |
| Foster Wayne | EVP, CAO | — | — |
| Polsky Bruce | Dir | — | — |
| DUNCAN BARBARA GAYLE | Dir | — | — |
| Corcoran Andrea | See Remarks | — | — |
Transactions 71
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Lucidi Bruno | Dir | M - OptEx | $0.00 | +29.6K | 142.3K | +26% | $0 |
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +29.6K | 536.1K | +6% | $0 |
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | DUNCAN BARBARA GAYLE | Dir | M - OptEx | $0.00 | +29.6K | 92.3K | +47% | $0 |
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Polsky Bruce | Dir | M - OptEx | $0.00 | +29.6K | 124.8K | +31% | $0 |
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Murphy Polly A. | Dir | M - OptEx | $0.00 | +29.6K | 121.7K | +32% | $0 |
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Adams Jerome M. | Dir | M - OptEx | $0.00 | +29.6K | 92.3K | +47% | $0 |
| A | 2026-05-21 18:30 | 2026-05-18 | AVIR | Murphy Polly A. | Dir | P - Purchase | $4.17 | +6,100 | 92.1K | +7% | +$25.4K |
| 2026-05-20 16:15 | 2025-05-18 | AVIR | Murphy Polly A. | Dir | P - Purchase | $4.17 | +6,100 | 92.1K | +7% | +$25.4K | |
| D | 2026-03-13 | 2026-03-11 | AVIR | Corcoran Andrea | See Remarks | M - OptEx | $1.24 | +60.0K | 823.6K | +8% | +$74.4K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Foster Wayne | EVP, CAO | F - Tax | $4.24 | -12.1K | 79.3K | -13% | -$51.4K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Foster Wayne | EVP, CAO | M - OptEx | — | +41.3K | 91.5K | +82% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +58.0K | 141.8K | +69% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | F - Tax | $4.24 | -14.1K | 127.7K | -10% | -$59.9K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Corcoran Andrea | See Remarks | M - OptEx | — | +54.9K | 779.7K | +8% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Corcoran Andrea | See Remarks | F - Tax | $4.24 | -16.1K | 763.6K | -2% | -$68.3K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | F - Tax | $4.24 | -16.1K | 96.1K | -14% | -$68.1K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | M - OptEx | — | +51.3K | 112.2K | +84% | — |
| DM | 2026-02-03 | 2026-01-31+ | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | $1.24 | +573.0K | 573.9K | +60,956% | +$710.5K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | F - Tax | $4.24 | -106.1K | 467.8K | -18% | -$449.8K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Vavricka John | Chief Commercial Off | F - Tax | $4.24 | -11.6K | 82.6K | -12% | -$49.1K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Vavricka John | Chief Commercial Off | M - OptEx | — | +42.1K | 94.2K | +81% | — |
| D | 2025-06-24 | 2025-06-20 | AVIR | Lucidi Bruno | Dir | M - OptEx | $0.00 | +29.6K | 112.8K | +36% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Murphy Polly A. | Dir | M - OptEx | $0.00 | +29.6K | 86.0K | +52% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +29.6K | 506.5K | +6% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Duncan Barbara Gayle | Dir | M - OptEx | $0.00 | +29.6K | 62.8K | +89% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Polsky Bruce | Dir | M - OptEx | $0.00 | +29.6K | 95.2K | +45% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Adams Jerome M. | Dir | M - OptEx | $0.00 | +29.6K | 62.8K | +89% | $0 |
| D | 2025-02-04 | 2025-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | A - Grant | — | +9,750 | 76.9K | +15% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | F - Tax | $3.06 | -16.1K | 60.9K | -21% | -$49.2K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | M - OptEx | — | +41.5K | 67.2K | +162% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Corcoran Andrea | See Remarks | F - Tax | $3.06 | -16.1K | 717.3K | -2% | -$49.3K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Corcoran Andrea | See Remarks | A - Grant | — | +10.5K | 733.4K | +1% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Corcoran Andrea | See Remarks | M - OptEx | — | +44.4K | 722.9K | +7% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Foster Wayne | EVP, CAO | M - OptEx | — | +33.3K | 54.2K | +160% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Foster Wayne | EVP, CAO | A - Grant | — | +8,000 | 62.2K | +15% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Foster Wayne | EVP, CAO | F - Tax | $3.06 | -12.1K | 50.1K | -19% | -$36.9K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +46.8K | 84.3K | +125% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | F - Tax | $3.06 | -14.1K | 81.4K | -15% | -$43.3K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | A - Grant | — | +11.2K | 95.5K | +13% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Vavricka John | Chief Commercial Off | A - Grant | — | +8,750 | 63.6K | +16% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Vavricka John | Chief Commercial Off | M - OptEx | — | +33.3K | 54.8K | +155% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Vavricka John | Chief Commercial Off | F - Tax | $3.06 | -11.5K | 52.1K | -18% | -$35.2K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | A - Grant | — | +99.5K | 389.5K | +34% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | — | +173.5K | 290.0K | +149% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | F - Tax | $3.06 | -88.6K | 300.9K | -23% | -$271.1K |
| MA | 2025-01-17 | 2025-01-15+ | AVIR | BERGER FRANKLIN M | Dir | P - Purchase | $3.26 | +25.0K | 476.9K | +6% | +$81.5K |
| M | 2025-01-17 | 2025-01-15+ | AVIR | BERGER FRANKLIN M | Dir | P - Purchase | $3.26 | -25.0K | 476.9K | -5% | -$81.5K |
| 2024-12-12 | 2024-12-10 | AVIR | BERGER FRANKLIN M | Dir | S - Sale | $2.85 | -359.6K | 451.9K | -44% | -$1.02M | |
| MTI | 2024-09-19 | 2024-09-17+ | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale | $4.04 | -58.0K | 5.87M | -1.0% | -$234.2K |
| D | 2024-06-21 | 2024-06-20 | AVIR | Polsky Bruce | Dir | S - Sale | $3.49 | -17.5K | 65.6K | -21% | -$61.2K |
| D | 2024-06-18 | 2024-06-16 | AVIR | Adams Jerome M. | Dir | M - OptEx | $0.00 | +33.1K | 33.1K | New | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Duncan Barbara Gayle | Dir | M - OptEx | $0.00 | +33.1K | 33.1K | New | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +33.1K | 811.5K | +4% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Polsky Bruce | Dir | M - OptEx | $0.00 | +33.1K | 83.2K | +66% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Lucidi Bruno | Dir | M - OptEx | $0.00 | +33.1K | 83.2K | +66% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Murphy Polly A. | Dir | M - OptEx | $0.00 | +33.1K | 56.4K | +142% | $0 |
| TI | 2024-06-07 | 2024-06-05 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale | $4.00 | -1,006 | 5.92M | -0.0% | -$4,024 |
| D | 2024-02-02 | 2024-02-01 | AVIR | Vavricka John | Chief Commercial Off | S - Sale+OE | $3.84 | -11.8K | 21.5K | -35% | -$45.4K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Vavricka John | Chief Commercial Off | M - OptEx | — | +33.3K | 33.3K | New | — |
| D | 2024-02-02 | 2024-02-01 | AVIR | Corcoran Andrea | See Remarks | S - Sale+OE | $3.84 | -15.8K | 670.2K | -2% | -$60.8K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Corcoran Andrea | See Remarks | M - OptEx | — | +44.4K | 686.1K | +7% | — |
| DT | 2024-02-02 | 2024-01-31 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | M - OptEx | — | +173.5K | 173.5K | New | — |
| DT | 2024-02-02 | 2024-02-01 | AVIR | Sommadossi Jean-Pierre | Pres, CEO, COB, Dir | S - Sale+OE | $3.85 | -56.9K | 116.6K | -33% | -$219.1K |
| D | 2024-02-02 | 2024-02-01 | AVIR | Hammond Janet MJ | Chief Development Off | S - Sale+OE | $3.84 | -14.0K | 35.4K | -28% | -$53.9K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +46.8K | 49.4K | +1,806% | — |
| D | 2024-02-02 | 2024-02-01 | AVIR | Horga Maria Arantxa | Chief Medical Off | S - Sale+OE | $3.84 | -15.9K | 25.7K | -38% | -$60.9K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | M - OptEx | — | +41.5K | 41.5K | New | — |
| D | 2024-02-02 | 2024-02-01 | AVIR | Foster Wayne | EVP, CAO | S - Sale+OE | $3.84 | -12.5K | 20.9K | -37% | -$47.9K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Foster Wayne | EVP, CAO | M - OptEx | — | +33.3K | 33.3K | New | — |
| M | 2022-11-15 | 2022-11-11+ | AVIR | BERGER FRANKLIN M | Dir | S - Sale | $5.15 | -41.7K | 778.4K | -5% | -$214.7K |
| 2021-12-21 | 2021-12-20 | AVIR | Murphy Polly A. | Dir | P - Purchase | $8.57 | +12.0K | 23.3K | +106% | +$102.8K |
Purchase Sale Sale after option exercise All abbreviations